| Título |
Fuente |
Fecha |
| Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes |
Translational Psychiatry 14 (1), 419 , 2024 |
2024 |
| Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice |
British Journal of Pharmacology 180 (18), 2361-2376 , 2023 |
2023 |
| Altered kynurenine pathway in abstinent patients diagnosed with alcohol use disorders and psychiatric comorbidity |
Alcohol 109, 98 , 2023 |
2023 |
| Barrera linguística, otro frente para avanzar en la internacionalización de la docencia Universitaria en Medicina |
|
2023 |
| Neurobiology of the kynurenine pathway and cannabis misuse: A new narrative |
Cannabis Use, Neurobiology, Psychology, and Treatment, 265-278 , 2023 |
2023 |
| Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice |
British Journal of Pharmacology 179 (14), 3711-3726 , 2022 |
2022 |
| Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3, 4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon … |
Neuropharmacology 187, 108490 , 2021 |
2021 |
| Addiction and the kynurenine pathway: A new dancing couple? |
Pharmacology & therapeutics 223, 107807 , 2021 |
2021 |
| Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward |
Elsevier , 2021 |
2021 |
| Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward |
Neuropharmacology 197, 108753 , 2021 |
2021 |
| Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity |
|
2020 |
| Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity |
Progress in Neuro-Psychopharmacology and Biological Psychiatry 102, 109958 , 2020 |
2020 |
| Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients |
Scientific Reports 9 (1), 16842 , 2019 |
2019 |
| Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice |
The FASEB Journal 33 (11), 12900 , 2019 |
2019 |
| Serotonina y fármacos que actúan sobre el sistema serotoninérgico. Purinas |
Velázquez. Farmacología básica y clínica, 461-470 , 2018 |
2018 |
| Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens |
Neuropharmacology 135, 581-591 , 2018 |
2018 |
| Effects of repeated social defeat on adolescent mice on cocaine‐induced CPP and self‐administration in adulthood: integrity of the blood–brain barrier |
Addiction biology 22 (1), 129-141 , 2017 |
2017 |
| Glutaminase and MMP-9 Downregulation in Cortex and Hippocampus of LPA 1 Receptor Null Mice Correlate with Altered Dendritic Spine Plasticity |
Frontiers in Molecular Neuroscience 10, 278 , 2017 |
2017 |
| 3, 4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus |
Neuropharmacology 118, 157-166 , 2017 |
2017 |
| Glutaminase and MMP-9 Downregulation in Cortex and Hippocampus of LPA1 Receptor Null Mice Correlate with Altered Dendritic Spine Plasticity |
Frontiers , 2017 |
2017 |
| Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge‐like drinking model |
Addiction biology 22 (4), 1103-1116 , 2017 |
2017 |
| A single neurotoxic dose of MDMA increases kynurenine pathway metabolism in plasma and hippocampus of rat |
Dianas: revista de dianas terapéuticas 5 (1) , 2016 |
2016 |
| Implicación de MMP-9 en los cambios de la permeabilidad de la barrera hematoencefálica y la formación de edema inducidos por MDMA en la rata |
Dianas: revista de dianas terapéuticas 5 (1) , 2016 |
2016 |
| SY21 BIOMARKERS AND DRUG TARGETS IN ALCOHOL ABUSE AND DEPENDENCE SY21-1 INCREASE IN BLOOD-BRAIN BARRIER PERMEABILITY IN POST-MORTEM ALCOHOLIC BRAIN: INVOLVEMENT OF TLR4 |
Alcohol and Alcoholism 50 (suppl_1), i24-i24 , 2015 |
2015 |
| INCREASE IN BLOOD-BRAIN BARRIER PERMEABILITY IN POST-MORTEM ALCOHOLIC BRAIN: INVOLVEMENT OF TLR4 |
ALCOHOL AND ALCOHOLISM 50 , 2015 |
2015 |
| DISRUPTION OF BLOOD-BRAIN BARRIER INTEGRITY IN POSTMORTEM HUMAN ALCOHOLIC BRAIN: 49 |
Basic & Clinical Pharmacology & Toxicology 115, 42 , 2014 |
2014 |
| Effect of intensive and repeated use of ethanol on the integrity of blood-brain barrier in mouse brain. Role of toll-like receptor 4 (TLR4) |
Basic & Clinical Pharmacology & Toxicology 115, 41 , 2014 |
2014 |
| Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine |
Neuropharmacology 87, 125-134 , 2014 |
2014 |
| EFFECT OF MDMA ON AQP4 EXPRESSION IN ASTROCYTIC ENDFEET AND TPA ACTIVITY IN RAT HIPPOCAMPUS: 50 |
Basic & Clinical Pharmacology & Toxicology 115, 42 , 2014 |
2014 |
| The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum |
International Journal of Neuropsychopharmacology 17 (2), 235-246 , 2014 |
2014 |
| 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X 7 receptors |
International Journal of Neuropsychopharmacology 17 (8), 1243-1255 , 2014 |
2014 |
| Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders |
Psychopharmacology 230, 125-135 , 2013 |
2013 |
| Implicación de la molécula de adhesión ALCAM en el daño cerebral: modelo de daño neuronal mediante la administración de MDMA/éxtasis en rata |
Trauma 24 (2), 101-108 , 2013 |
2013 |
| A study on the effect of JNK inhibitor, SP600125, on the disruption of blood–brain barrier induced by methamphetamine |
Neurobiology of disease 50, 49-58 , 2013 |
2013 |
| ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9 |
Cellular and Molecular Life Sciences 70 (3), 475-493 , 2013 |
2013 |
| Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine |
Neurobiology of disease 45 (2), 810-820 , 2012 |
2012 |
| Changes in the serotonergic system and in brain-derived neurotrophic factor distribution in the main olfactory bulb of pcd mice before and after mitral cell loss |
Neuroscience 201, 20-33 , 2012 |
2012 |
| Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication |
Stroke 43 (6), 1647-1653 , 2012 |
2012 |
| Apolipoprotein-E controls ATP-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication: P2091 |
European Journal of Neurology 19, 489 , 2012 |
2012 |
| Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA |
Neurobiology of disease 42 (3), 391-403 , 2011 |
2011 |
| Changes in interleukin-1 signal modulators induced by 3, 4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity |
Journal of Neuroinflammation 8, 1-14 , 2011 |
2011 |
| INNOVATIONS IN PHARMACOLOGY EVALUATION: PILOT STUDY ON THE PARTICIPATION OF STUDENTS IN" FUNDAMENTOS DE FARMACOLOGIA EN FISIOTERAPIA'' |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 28-28 , 2011 |
2011 |
| PRECLININCAL AND CLINICAL STUDIES ON THE INTERACTION OF MDMA WITH OTHER RECREATIONAL DRUGS |
JOURNAL OF PSYCHOPHARMACOLOGY 25 (8), A1-A1 , 2011 |
2011 |
| Changes in interleukin-1 signal modulators induced by 3, 4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity |
Journal of neuroinflammation 8 (1), 53 , 2011 |
2011 |
| The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9 |
Cellular and Molecular Life Sciences 68, 3275-3292 , 2011 |
2011 |
| Functional interplay between tetraspanins and proteases |
Cellular and Molecular Life Sciences 68, 3323-3335 , 2011 |
2011 |
| Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA |
Journal of Neuroinflammation 8, 1-11 , 2011 |
2011 |
| Increased interleukin-1b levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA |
|
2011 |
| Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum |
Psychopharmacology 207 (4), 671 , 2010 |
2010 |
| Involvement of 2‐arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine |
British journal of pharmacology 160 (3), 772-783 , 2010 |
2010 |
| Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum |
Psychopharmacology 207, 671-679 , 2010 |
2010 |
| Sex-dependent maternal deprivation effects on brain monoamine content in adolescent rats |
Neuroscience letters 479 (2), 112-117 , 2010 |
2010 |
| Evidence that MDMA (‘ecstasy’) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain |
Journal of neurochemistry 113 (1), 67-78 , 2010 |
2010 |
| Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration: early loss of TH in striosomes after methamphetamine |
Neurotoxicity research 18, 48-58 , 2010 |
2010 |
| Dopamine transporter down‐regulation following repeated cocaine: implications for 3, 4‐methylenedioxymethamphetamine‐induced acute effects and long‐term neurotoxicity in mice |
British journal of pharmacology 159 (1), 201-211 , 2010 |
2010 |
| A study on the mechanisms by which minocycline protects against MDMA (‘ecstasy’)-induced neurotoxicity of 5-HT cortical neurons |
Neurotoxicity research 18, 187-199 , 2010 |
2010 |
| 3, 4-Methylenedioxymethamphetamine (MDMA," Ecstasy") |
Encyclopedia of Neuroscience, 827-833 , 2009 |
2009 |
| Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement |
International Journal of Neuropsychopharmacology 12 (7), 929-940 , 2009 |
2009 |
| Immunological synapse formation inhibits, via NF-κB and FOXO1, the apoptosis of dendritic cells |
Nature immunology 10 (7), 753-760 , 2009 |
2009 |
| Neurotoxic doses of METH increase ethanol consumption and preference: Involvement of endocannabinoid systemP060 |
Fundamental and Clinical Pharmacology 22, 70 , 2008 |
2008 |
| Éxtasis (MDMA) y drogas de diseño: estructura, farmacología, mecanismos de acción y efectos en el ser humano |
Trastornos adictivos 10 (3), 175-182 , 2008 |
2008 |
| Effect of ethanol on GABA turnover in the brain of mice treated with a neurotoxic dose of MDMA: P140 |
Fundamental and Clinical Pharmacology 22, 88-89 , 2008 |
2008 |
| Evidence that JWH015 (CB2 agonist) reduces MDMA-induced neuroin-flammation but fails to provide protection: P059 |
Fundamental and Clinical Pharmacology 22, 70 , 2008 |
2008 |
| Persistent MDMA‐induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice |
Journal of neurochemistry 107 (4), 1102-1112 , 2008 |
2008 |
| Early loss of dopaminergic terminals in striosomes after MDMA administration to mice |
Synapse 62 (1), 80-84 , 2008 |
2008 |
| Éxtasis líquido: estructura, farmacología, efectos adversos y mecanismos de acción |
Trastornos adictivos 10 (3), 190-194 , 2008 |
2008 |
| Repeated low dose MDMA protects against a subsequent neurotoxic dose of MDMA and reduces IL-1β release: P139 |
Fundamental and Clinical Pharmacology 22, 88 , 2008 |
2008 |
| Cocaine withdrawal internalizes DAT in the endosome and prevents MDMA-induced dopaminergic toxicity in mouse striatum: P141 |
Fundamental and Clinical Pharmacology 22, 89 , 2008 |
2008 |
| Éxtasis (MDMA): estudios neurobiológicos en el laboratorio |
Trastornos adictivos 10 (3), 183-189 , 2008 |
2008 |
| Éxtasis líquido: estudios neurobiológicos en el laboratorio |
Trastornos adictivos 10 (3), 195-200 , 2008 |
2008 |
| Implication of the tetraspanin CD9 in the immune system and cancer |
Inmunología 26 (2), 65-72 , 2007 |
2007 |
| NEUROPHARMACOLOGY-Mice with Decreased Cerebral Dopamine Function following a Neurotoxic Dose of MDMA (3, 4-Methylenedioxymethamphetamine," Ecstasy") Exhibit Increased Ethanol … |
Journal of Pharmacology and Experimental Therapeutics 322 (3), 1003-1012 , 2007 |
2007 |
| Changes in the serotonergic system in the main olfactory bulb of rats unilaterally deprived from birth to adulthood |
Journal of neurochemistry 100 (4), 924-938 , 2007 |
2007 |
| Factors contributing to the enhancement of MDMA-induced 5-HT depletion by ethanol: a reply to Byron and Cassel |
Psychopharmacology 190, 581-582 , 2007 |
2007 |
| Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain |
Psychopharmacology 189, 459-470 , 2007 |
2007 |
| Sex differences in catechol contents in the olfactory bulb of control and unilaterally deprived rats |
European Journal of Neuroscience 25 (5), 1517-1528 , 2007 |
2007 |
| The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells |
International journal of cancer 121 (10), 2140-2152 , 2007 |
2007 |
| Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3, 4‐methylenedioxymethamphetamine toxicity in rat brain |
Journal of neurochemistry 101 (5), 1272-1283 , 2007 |
2007 |
| Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3, 4-methylenedioxymethamphetamine,“Ecstasy”) exhibit increased ethanol consumption and … |
The Journal of pharmacology and experimental therapeutics 322 (3), 1003-1012 , 2007 |
2007 |
| MDMA and Other “Club Drugs” |
Handbook of Contemporary Neuropharmacology , 2007 |
2007 |
| MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature |
British journal of pharmacology 148 (6), 778-785 , 2006 |
2006 |
| 6.2. Alucinógenos, anfetaminas y drogas de síntesis. 6.2. 1. Bases biológicas |
Tratado SET de Trastornos Adictivos, 181-187 , 2006 |
2006 |
| Differential effects of unilateral olfactory deprivation on noradrenergic and cholinergic systems in the main olfactory bulb of the rat |
Neuroscience 141 (4), 2117-2128 , 2006 |
2006 |
| Activation pathways of α4β1 integrin leading to distinct T‐cell cytoskeleton reorganization, Rac1 regulation and Pyk2 phosphorylation |
Journal of cellular physiology 207 (3), 746-756 , 2006 |
2006 |
| The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice |
Journal of Psychopharmacology 20 (2), 264-271 , 2006 |
2006 |
| Studies on heat loss by the tails of rats administered a neurotoxic dose of MDMA |
JOURNAL OF PSYCHOPHARMACOLOGY 19 (5), A26-A26 , 2005 |
2005 |
| The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature. |
Springer Verlag , 2005 |
2005 |
| Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats |
Neuropsychopharmacology 30 (7), 1312-1323 , 2005 |
2005 |
| A comparative study on the acute and long‐term effects of MDMA and 3, 4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after ip or striatal administration in mice |
British journal of pharmacology 144 (2), 231-241 , 2005 |
2005 |
| Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures |
British journal of pharmacology 146 (2), 306-312 , 2005 |
2005 |
| 3, 4-Methylenedioxymethamphetamine increases pro-interleukin-1β production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: Role … |
Neuroscience 135 (4), 1095-1105 , 2005 |
2005 |
| 3, 4-Methylenedioxymethamphetamine increases pro-interleukin-production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: Role of … |
Neuroscience 135 (4), 1095-1106 , 2005 |
2005 |
| Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation |
Blood 105 (7), 2852-2861 , 2005 |
2005 |
| S35 ROLE OF MICROGLIA AND CYTOKINES IN MDMA-INDUCED LONG-TERM NEUROTOXICITY |
Behavioural Pharmacology 16, S12 , 2005 |
2005 |
| Studies on the effect of MDMA (ecstasy) on the body temperature of rats housed at different ambient room temperatures. |
Nature Publishing Group , 2005 |
2005 |
| The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature |
Psychopharmacology 179, 884-890 , 2005 |
2005 |
| Serotonina y fármacos antiserotoninérgicos. Purinas |
Velázquez. Farmacología Básica y Clínica, 477-485 , 2004 |
2004 |
| Heat pretreatment increases MDMA-induced heat shock protein 70 expression in the rat cortex but does not protect against 5-HT neurodegeneration |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 150-150 , 2004 |
2004 |
| Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones |
Journal of psychopharmacology 18 (3), 412-416 , 2004 |
2004 |
| Efecto del selenio en dieta sobre la neurotoxicidad inducida por MDMA (" éxtasis") en cerebro de ratón |
MAPFRE med, 53-62 , 2004 |
2004 |
| A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response |
European journal of pharmacology 500 (1-3), 3-13 , 2004 |
2004 |
| Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function |
Psychopharmacology 173, 249-263 , 2004 |
2004 |
| Long-lasting brain 5-HT deficits induced by a single MDMA administration to dark Agouti rats |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A39-A39 , 2004 |
2004 |
| 3, 4-Methylenedioxymethamphetamine (MDMA,'ecstasy') activates microglia in rat brain by a process not dependent on hyperthermia |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 120-120 , 2004 |
2004 |
| MDMA-is serotonin the only target for neurotoxicity? |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A7-A7 , 2004 |
2004 |
| Éxtasis y cerebro |
XXVI Congreso SEBBM, A Coruña 16-18 de septiembre 2003: mesas redondas de … , 2004 |
2004 |
| MDMA metabolism: Source of neuroactive compounds |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A7-A7 , 2004 |
2004 |
| Decreased 5-HT function following a neurotoxic dose of MDMA results in impaired thermoregulation |
Journal of Psychopharmacology 18 (3), A38-A38 , 2004 |
2004 |
| A comparative study of the brain monoamine changes induced by intrastriatal or peripheral administration of MDMA and DHMA to mice |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 149-149 , 2004 |
2004 |
| The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test |
Pharmacology Biochemistry and Behavior 77 (4), 805-814 , 2004 |
2004 |
| Hyperthermic and neurotoxic effect of 3, 4-methylenedioxymethamphetamine (MDMA) in guinea pigs |
Psychopharmacology 173, 452-453 , 2004 |
2004 |
| Signaling through the leukocyte integrin LFA-1 in T cells induces a transient activation of Rac-1 that is regulated by Vav and PI3K/Akt-1 |
Journal of Biological Chemistry 279 (16), 16194-16205 , 2004 |
2004 |
| 3, 4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletion |
Journal of neurochemistry 89 (6), 1445-1453 , 2004 |
2004 |
| Role of interleukin-1 beta in the acute and long-term effects of MDMA |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 133-133 , 2004 |
2004 |
| Effect of ambient temperature and a prior neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge … |
Psychopharmacology 173, 264-269 , 2004 |
2004 |
| New targets for preventing MDMA neurotoxicity in rats |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 13-13 , 2004 |
2004 |
| Attenuation of defensive burying by mice following MDMA, methamphetamine and methylphenidate |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A39-A39 , 2004 |
2004 |
| An elevation of ambient room temperature enhances the MDMA-induced dopamine and 5-HT release in the nucleus accumbens but not in the striatum of rats |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 123-123 , 2004 |
2004 |
| Serotonin and MDMA-induced hyperthermia |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 133-133 , 2004 |
2004 |
| Changes induced by MDMA in pro-IL-1 beta levels in rat brain and influence of ambient room temperature |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 90-90 , 2004 |
2004 |
| Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats |
Neuropharmacology 44 (4), 449-461 , 2003 |
2003 |
| SUSTAINED MDMA-INDUCED INHIBITION OF TRYPTOPHAN HYDROXYLASE ACTIVITY LEADS TO THE LONG-TERM CEREBRAL 5-HT LOSS. |
British Journal of Pharmacology 140 , 2003 |
2003 |
| The nNOS inhibitor, AR‐R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum |
Journal of neurochemistry 85 (2), 515-524 , 2003 |
2003 |
| INTRACEREBROVENTRICULAR INTERLEUKIN-1Β EXACERBATES MDMA-INDUCED NEUROTOXICITY BY AN ADDITIVE EFFECT ON RECTAL TEMPERATURE. |
British Journal of Pharmacology 140 , 2003 |
2003 |
| Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy) |
Brain research 987 (2), 144-154 , 2003 |
2003 |
| Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke |
The FASEB journal 17 (14), 1-17 , 2003 |
2003 |
| EVIDENCE THAT MDMA ('ECSTACY') INCREASES INTERLEUKIN-1Β LEVELS IN RAT BRAIN. |
British Journal of Pharmacology 140 , 2003 |
2003 |
| Effect of ambient temperature and 3, 4-methylenedioxymethamphetamine (MDMA) pretreatment on the hyperthermic response of rats to a low dose of MDMA |
BRITISH JOURNAL OF PHARMACOLOGY 138, U98-U98 , 2003 |
2003 |
| The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”) |
Pharmacological reviews 55 (3), 463-508 , 2003 |
2003 |
| Effects of MDMA pretreatment upon drug reward. |
Psychopharmacology 166 (4) , 2003 |
2003 |
| Formation of glutathione adduct metabolites of MDA in human liver microsomes is related to CYP2D6 activity |
BRITISH JOURNAL OF PHARMACOLOGY 138, U97-U97 , 2003 |
2003 |
| A Functionally Relevant Conformational Epitope on the CD9 Tetraspanin Depends on the Association with Activated β1Integrin |
Journal of Biological Chemistry 278 (1), 208-218 , 2003 |
2003 |
| On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor |
Psychopharmacology 165, 317-319 , 2003 |
2003 |
| Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse |
Psychopharmacology 166, 383-390 , 2003 |
2003 |
| Is frequent dosing with ecstasy a risky business for dopamine-containing neurons? |
Trends in pharmacological sciences 24 (6), 272-274 , 2003 |
2003 |
| Neurobiología del éxtasis |
Ibérica: Actualidad tecnológica, 520-526 , 2003 |
2003 |
| Methamphetamine induces a long term loss of neurofilament protein NF68 in mouse striatum |
BRITISH JOURNAL OF PHARMACOLOGY 135 , 2002 |
2002 |
| The pharmacology of the acute hyperthermic response that follows administration of 3, 4‐methylenedioxymethamphetamine (MDMA,‘ecstasy’) to rats |
British journal of pharmacology 135 (1), 170-180 , 2002 |
2002 |
| c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription |
Molecular and cellular biology 22 (1), 12-22 , 2002 |
2002 |
| Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced … |
Journal of neurochemistry 81 (5), 961-972 , 2002 |
2002 |
| Role of the von Hippel-Lindau tumor suppressor gene in the formation of β1-integrin fibrillar adhesions |
Cancer Research 62 (10), 2929-2936 , 2002 |
2002 |
| A selenium deficient diet potentiates the long term loss of striatal dopamine induced by MDMA in mice and induces depletion of cortical 5-HT |
British Journal of Pharmacology 135 , 2002 |
2002 |
| Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance |
Journal of Cerebral Blood Flow & Metabolism 22 (11), 1297-1302 , 2002 |
2002 |
| Protection against 3, 4‐methylenedioxymethamphetamine‐induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia |
Journal of neurochemistry 81 (4), 686-695 , 2002 |
2002 |
| 3, 4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected … |
Psychopharmacology 154, 251-260 , 2001 |
2001 |
| NEUROPHARMACOLOGY-A study of the mechanisms involved in the neurotoxic action of 3, 4-methylenedioxymethamphetamine (MDMA,'ecstasy') on dopamine neurones in mouse brain |
British Journal of Pharmacology 134 (8), 1711-1723 , 2001 |
2001 |
| A study of the mechanisms involved in the neurotoxic action of 3, 4‐methylenedioxymethamphetamine (MDMA,‘ecstasy’) on dopamine neurones in mouse brain |
British journal of pharmacology 134 (8), 1711-1723 , 2001 |
2001 |
| Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain |
Neuropharmacology 40 (1), 65-74 , 2001 |
2001 |
| A neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation |
Psychopharmacology 155, 413-418 , 2001 |
2001 |
| The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain |
British Journal of Pharmacology 134 (1), 46-57 , 2001 |
2001 |
| Abstracts-Role of Glutathione in 3, 4-Methylenedioxymethamphetamine-Induced Neurodegeneration in Dark Agouti Rats |
Proceedings of the Western Pharmacology Society 44, 258 , 2001 |
2001 |
| Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats |
Journal of neurochemistry 79 (2), 456-459 , 2001 |
2001 |
| Efecto de la fluoxetina y GBR 12909 frente a la neurotoxicidad inducida por MDMA («éxtasis») en rata y ratón |
Mapfre Medicina 12 (4), 250-260 , 2001 |
2001 |
| Intracellular redistribution of nucleolin upon interaction with the CD3ε chain of the T cell receptor complex |
Journal of Biological Chemistry 276 (14), 11174-11179 , 2001 |
2001 |
| Abstracts-The Synthesis and Purification of 5-(Glutathion-S-yl)-(a-Methyidopamine and Formation of a Structurally Related GSH Regioisomer |
Proceedings of the Western Pharmacology Society 44, 255-255 , 2001 |
2001 |
| Studies on the mechanisms involved in the degeneration of dopamine nerve endings in mouse brain following administration of MDMA (Ecstasy') |
BRITISH JOURNAL OF PHARMACOLOGY 134 (6; SUPP), 142P-142P , 2001 |
2001 |
| Prevention of 3, 4-methylenedioxymethamphetamine (MDMA, ECSTASY) induced neurodegeneration by the clomethiazole analogue Ar-A008055 |
BRITISH JOURNAL OF PHARMACOLOGY 133, U70-U70 , 2001 |
2001 |
| Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA (" ecstasy")-induced neurodegeneration in rat … |
Psychopharmacology 157, 82-88 , 2001 |
2001 |
| AVANCES EN LA PREVENCION DE LOS TRASTORNOS POR DROGAS DE SINTESIS |
ADICCIONES-PALMA DE MALLORCA- 12, 22-22 , 2000 |
2000 |
| EFECTO DE GBR 12,909 SOBRE LA PERDIDA DE DOPAMINA A CORTOY LARGO PLAZO INDUCIDA POR LA ADMINISTRACION REPETIDA DE MDMA (" extasis") FN RATON |
ADICCIONES-PALMA DE MALLORCA- 12, 95-95 , 2000 |
2000 |
| EFECTO NEUROTOXICO DE MDMA (" extasis") SOBRE LOS TERMINALES SEROTONINERGICOS TRAS SU ADMINISTRACION INTRACEREBRAL DIRECTA, COMPARACION CON 5, 7-DHT |
ADICCIONES-PALMA DE MALLORCA- 12, 59-59 , 2000 |
2000 |
| Effects of neurotensin on cognitive behaviour and brain neurotransmitter amines |
EUROPEAN JOURNAL OF NEUROSCIENCE 12, 96-96 , 2000 |
2000 |
| Evidence against MDMA-induced hyperthermia being mediated by 5-HT release in the brain |
BRITISH JOURNAL OF PHARMACOLOGY 131, U6-U6 , 2000 |
2000 |
| Phosphodiesterases 4D and 7A Splice Variants in the Response of HUVEC Cells to TNF-α1 |
Biochemical and biophysical research communications 274 (2), 415-421 , 2000 |
2000 |
| FLUOXETINA, TRAS UN PERIODO DE LAVADO, ATENUA LA NEURODEGENERACION INDUCIDA POR MDMA (" extasis") SOBRE LOS TERMINALES SEROTONINERGICOS |
ADICCIONES-PALMA DE MALLORCA- 12, 96-96 , 2000 |
2000 |
| Altered thermoregulatory response to high ambient temperature (30 C) in MDMA-pretreated rats |
BRITISH JOURNAL OF PHARMACOLOGY 128, 185P-185P , 1999 |
1999 |
| In vivo evidence against clomethiazole being neuroprotective against MDMA (‘ecstasy’)-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism |
Neuropharmacology 38 (2), 307-314 , 1999 |
1999 |
| Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration |
Psychopharmacology 142, 421-425 , 1999 |
1999 |
| Similar brain concentrations of MDMA have different neurotoxic effects following central or peripheral drug administration |
British Journal of Pharmacology 127, U40-U40 , 1999 |
1999 |
| The Acute Effect in Rats of 3, 4‐Methylenedioxyethamphetamine (MDEA,“Eve”) on Body Temperature and Long Term Degeneration of 5‐HT Neurones in Brain: A Comparison with MDMA … |
Pharmacology & toxicology 84 (6), 261-266 , 1999 |
1999 |
| Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3, 4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy … |
British journal of pharmacology 126 (4), 911-924 , 1999 |
1999 |
| Effect of 7-nitroindazole on the hypothermia and the striatal dopamine loss induced by MDMA in mice |
BRITISH JOURNAL OF PHARMACOLOGY 127, U40-U40 , 1999 |
1999 |
| Modulation of adrenergic receptors during left ventricular hypertrophy development and after regression by captopril |
Journal of cardiovascular pharmacology 34 (4), 505-511 , 1999 |
1999 |
| NEUROPHARMACOLOGY-Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3, 4-methylenedioxymethamphetamine (MDMA … |
British Journal of Pharmacology 126 (4), 911-924 , 1999 |
1999 |
| Further evidence that NMDA antagonists protect against MDMA ('ecstasy')-induced neurodegeneration because of hypothermia |
British Journal of Pharmacology-Proceedings Supplement, 259P , 1998 |
1998 |
| Evidence against clomethiazole preventing MDMA-induced neurodegeneration by free radical scavenging |
British Journal of Pharmacology-Proceedings Supplement, 43P , 1998 |
1998 |
| Role of body temperature in the protective action of haloperidol against MDMA-induced neurodegeneration |
British Journal of Pharmacology-Proceedings Supplement, 44P , 1998 |
1998 |
| The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (ecstasy') |
Neuropharmacology 37 (7), 919-926 , 1998 |
1998 |
| Further evidence that NMDA antagonists against MDMA ('ecstasy')-induced neurodegeneration because of hypothermia |
BRITISH JOURNAL OF PHARMACOLOGY 123, U149-U149 , 1998 |
1998 |
| Implicación de los radicales libres en la neurodegeneración inducida por 3, 4-metilenodioximetanfetamina (mdma) |
Universidad Complutense de Madrid , 1998 |
1998 |
| Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR |
British journal of pharmacology 124 (3), 479-484 , 1998 |
1998 |
| The role of temperature in the neuroprotective effect of clomethiazole against MDMA-induced degeneration in rat brain |
British Journal of Pharmacology-Proceedings Supplement, 304P , 1997 |
1997 |
| Evidence that MDMA ('ecstasy'), but not fenfluramine, increases free radical formation in rat brain |
BRITISH JOURNAL OF PHARMACOLOGY 120, P264-P264 , 1997 |
1997 |
| A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy |
British Journal of Pharmacology 121 (4), 827-833 , 1997 |
1997 |
| In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p ‐chloroamphetamine but not … |
British journal of pharmacology 121 (5), 889-900 , 1997 |
1997 |
| Relationship between the dose of MDMA and frequency of administration on the subsequent neurodegeneration of rat brain 5-HT |
British Journal of Pharmacology-Proceedings Supplement, 303P , 1997 |
1997 |
| Effect of prenatal exposure to MDMA ('ecstasy') on cerebral 5-HT content of neonate rats |
BRITISH JOURNAL OF PHARMACOLOGY 120, P263-P263 , 1997 |
1997 |
| Behavioral and analgesic effects induced by administration of nifedipine and nimodipine |
Pharmacology Biochemistry and Behavior 55 (1), 93-98 , 1996 |
1996 |
| Effect of the spin trap reagent PBN on degeneration of 5-HT neurones induced by p-chloroamphetamine or fenfluramine administration |
British Journal of Pharmacology-Proceedings Supplement, 123P , 1996 |
1996 |
| HLA-DR, DQ and anti-GAD antibodies in first degree relatives of type I diabetes mellitus |
Diabetes research and clinical practice 34, S133-S139 , 1996 |
1996 |
| The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine |
Neuropharmacology 35 (11), 1615-1620 , 1996 |
1996 |
| Molecular IDDM epidemiology: international studies |
Diabetes research and clinical practice 34, S107-S116 , 1996 |
1996 |
| Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children |
Journal of Molecular Medicine 74, 105-109 , 1996 |
1996 |
| FACTORES IMPLICADOS EN LA ANALGESIA INDUCIDA POR CALCITONINA |
FACTORES IMPLICADOS EN LA ANALGESIA INDUCIDA POR CALCITONINA 10 (2), 102-111 , 1995 |
1995 |
| Calcitonin onin vitro opioid withdrawal |
Pharmacological Research 31, 113 , 1995 |
1995 |
| CONSIDERACIONES GENERALES: ASPECTOS FUNDAMENTALES DE LA FISIOLOGIA Y LA FARMACOLOGIA DE LA CALCITONINA |
CONSIDERACIONES GENERALES: ASPECTOS FUNDAMENTALES DE LA FISIOLOGIA Y LA … , 1995 |
1995 |
| ESTUDIOS IN VITRO CON CALCITONINA: MECANISMOS OPIOIDES Y NO OPIOIDES IMPLICADOS EN LA ANALGESIA |
ESTUDIOS IN VITRO CON CALCITONINA: MECANISMOS OPIOIDES Y NO OPIOIDES … , 1995 |
1995 |
| VIAS DE ADMINISTRACION DE LA CALCITONINA |
VIAS DE ADMINISTRACION DE LA CALCITONINA 10 (2), 112-117 , 1995 |
1995 |
| Effect of 8-OH-DPAT in analgesia induced by salmon calcitonin |
Pharmacological Research 31, 160 , 1995 |
1995 |
| Naltrexone administration during the preweanling period affects striatal and hypothalamic serotonergic systems, but not midbrain serotonergic or striatal dopaminergic systems … |
Neuroscience letters 201 (3), 195-198 , 1995 |
1995 |
| The spin trap reagent α-phenyl-N-tert-butylnitrone prevents ‘ecstasy’-induced neurodegeneration of 5-hydroxytryptamine neurones |
European journal of pharmacology 280 (3), 343-346 , 1995 |
1995 |
| Genetic analysis of HLA DRB1, DQA1 and DQB1 alleles and susceptibility to IDDM in Chilean subjects. Chile IDDM Study Group |
Diabetologia , 1995 |
1995 |
| The hyperthermic and neurotoxic effects of ‘Ecstasy’(MDMA) and 3, 4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype |
British journal of pharmacology 115 (7), 1281-1289 , 1995 |
1995 |
| CONSIDERACIONES CLINICAS SOBRE LA UTILIDAD DEL EFECTO ANALGESICO DE LA CALCITONINA |
CONSIDERACIONES CLINICAS SOBRE LA UTILIDAD DEL EFECTO ANALGESICO DE LA … , 1995 |
1995 |
| Chlormethiazole and Dizocilpine Block the Behavioural, but Not the Neurotoxic Effects of 5, 7‐Dihydroxytryptamine in Mice |
Pharmacology & toxicology 74 (1), 40-42 , 1994 |
1994 |
| Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse |
European journal of pharmacology 252 (3), 291-297 , 1994 |
1994 |
| Lipoprotein (a), atherosclerosis, and diabetes mellitus |
Revista medica de Chile 122 (10), 1189-1195 , 1994 |
1994 |
| Naltrexone administration effects on regional brain monoamines in developing rats |
Brain research bulletin 34 (4), 395-406 , 1994 |
1994 |
| A study of the mechanism of MDMA (‘Ecstasy’)‐induced neurotoxicity of 5‐HT neurones using chlormethiazole, dizocilpine and other protective compounds |
British journal of pharmacology 111 (1), 131-136 , 1994 |
1994 |
| Lipoprotein (a) and other risk factors in Chilean children with type I diabetes mellitus |
Revista medica de Chile 122 (10), 1115-1119 , 1994 |
1994 |
| Neonatal guanethidine sympathectomy suppresses autotomy and prevents changes in spinal and supraspinal monoamine levels induced by peripheral deafferentation in rats |
Pain 56 (1), 3-8 , 1994 |
1994 |
| Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes. |
Diabete & metabolisme 20 (6), 522-525 , 1994 |
1994 |
| Effect of nimodipine, diltiazem and BAY K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with … |
General pharmacology 24 (1), 35-41 , 1993 |
1993 |
| In vitro study of the interaction of salmon calcitonin with μ, δ and κ opioid agonists |
Naunyn-Schmiedeberg's archives of pharmacology 347, 324-328 , 1993 |
1993 |
| Molecular mechanisms of pain: serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons |
Neuron 10 (4), 599-611 , 1993 |
1993 |
| Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5‐hydroxytryptamine in various brain areas of the rat |
Journal of pharmacy and pharmacology 45 (3), 220-222 , 1993 |
1993 |
| 5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p ‐chloroamphetamine and fenfluramine administration and effects of … |
British journal of pharmacology 108 (3), 583-589 , 1993 |
1993 |
| Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine |
British journal of pharmacology 108 (3), 590 , 1993 |
1993 |
| EFFECT OF NIMODIPINE, DILTIAZEM AND BAY K 8644 |
|
1993 |
| STUDY OF ALGESIA AND MOTILITY IN RATS OF DIFFERENT AGES |
Behavioural Pharmacology 3, 78 , 1992 |
1992 |
| CHLORMETHIAZOLE, BUT NOT DIZOCILPINE, INHIBITS DOPAMINE RELEASE IN RAT STRIATUM INDUCED BY HIGH-DOSE METHAMPHETAMINE |
BRITISH JOURNAL OF PHARMACOLOGY 107, P298-P298 , 1992 |
1992 |
| Effects of Opioid and α 2 -Adrenoceptor Agonists on the Isolated Ileum of Morphine-dependent Guinea-pigs During Withdrawal and After Clonidine Treatment |
Journal of pharmacy and pharmacology 44 (2), 101-104 , 1992 |
1992 |
| Analgesic effect of salmon-calcitonin administered by two routes. Effect on morphine analgesia |
European journal of pharmacology 224 (1), 77-82 , 1992 |
1992 |
| Susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQ α Arg 52 and HLA-DQ β non … |
Diabetologia 35, 583-588 , 1992 |
1992 |
| SALMON-CALCITONIN ADMINISTERED INTRACEREBROVENTRICULARLY POTENTIATE MORPHINE ANALGESIC EFFECT IN MICE |
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY 418 (6), R187-R187 , 1991 |
1991 |
| Calcitonin increases the inhibitory effect of opioids in guinea-pig ileum. |
General pharmacology 22 (1), 73-75 , 1991 |
1991 |
| The effect of dihydropyridine calcium channel agents on 5-HT metabolism in the CNS of the rat |
Journal of pharmacy and pharmacology 43 (9), 662-664 , 1991 |
1991 |
| EFFECTS OF DIHYDROPYRIDINE DERIVATIVES ON MONOAMINE LEVELS IN RAT CENTRAL-NERVOUS-SYSTEM |
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY 418 (6), R186-R186 , 1991 |
1991 |
| Effect of cinitapride in isolated ileum obtained from guinea-pigs treated with morphine. |
General pharmacology 22 (5), 863-866 , 1991 |
1991 |
| Acute treatment with clonidine or calcium entry blockers on opioid withdrawal in guinea-pig ileum |
Journal of pharmacy and pharmacology 42 (10), 743-744 , 1990 |
1990 |
| Central biochemical and behavioural effects of calcium channel agonist and antagonists in morphine-dependent rats |
European Journal of Pharmacology 183 (2), 490-491 , 1990 |
1990 |
| Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum |
British journal of pharmacology 101 (4), 958 , 1990 |
1990 |
| Interaction of calcitonin and opioid receptor in guinea pig ileum |
European Journal of Pharmacology 183 (6), 2423 , 1990 |
1990 |
| Salmon calcitonin administered intraperitoneally potentiate morphine analgesic effect in mice |
European Journal of Pharmacology 183 (3), 979 , 1990 |
1990 |
| Pain relief in humans by chromaffin tissue graft into medullary arachnoid |
Trasplante-Journal of Organ and Tissue Transplantation 1 (1), 39-42 , 1989 |
1989 |
| Tolerance and withdrawal syndrome in guinea pig ileum treated with morphine suspension. Comparative study |
Revista de Farmacologia Clinica y Experimental 6 (2), 65-69 , 1989 |
1989 |
| Nifedipine reversal of decreased serotonin metabolite levels during morphine withdrawal. |
Archives internationales de pharmacodynamie et de thérapie 298, 61-67 , 1989 |
1989 |
| Unilateral dorsal rhizotomy decreases monoamine levels in the rat spinal cord |
Neuroscience letters 87 (3), 302-306 , 1988 |
1988 |
| Transplantation of adrenal medulla into spinal cord for pain relief: Disappointing outcome |
The Lancet 332 (8623), 1315 , 1988 |
1988 |
| Sensitivity of the myenteric plexus alpha2-receptor from guinea pig treated with clonidine or guanfacine |
Archivos de farmacologia y toxicologia 10 (2), 115-119 , 1984 |
1984 |
| GUANFACINE IN THE LONGITUDINAL VEIN MYENTERIC PLEXUS OF THE GUINEA-PIG |
JOURNAL DE PHARMACOLOGIE 14 (4), 613-613 , 1983 |
1983 |
| SENSITIVITY TO MORPHINE IN THE ILEUM OF GUINEA-PIGS DEPENDENT ON CLONIDINE TREATMENT |
JOURNAL DE PHARMACOLOGIE 14 (4), 548-548 , 1983 |
1983 |
| SENSITIVITY OF ALPHA-2 RECEPTORS IN THE ILEUM OF GUINEA-PIGS TREATED WITH CLONIDINE AND GUANFACINE |
JOURNAL DE PHARMACOLOGIE 14 (4), 501-501 , 1983 |
1983 |
| Influences on morphine action in the myenteric plexus from guinea pig of alpha 2 receptor stimulation. |
Archivos de Farmacología y Toxicología 9 (3), 217-224 , 1983 |
1983 |
